TRIM31 and nasopharyngeal carcinoma: Our data now provide novel clues linking reduction of NPC risk with non-HLA genes near TRIM31 and TRIM39 or TRIM39-RPP21 loci independent of the HLA Class I and II alleles and HLA-A/B/C amino acid variants.